Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

ARTAÇ M., Bozcuk H., Kiyici A., Eren O. O., Boruban M. C., Ozdogan M.

BREAST CANCER, cilt.20, sa.2, ss.174-180, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s12282-011-0322-1
  • Dergi Adı: BREAST CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.174-180
  • Anahtar Kelimeler: Metastatic breast cancer, Leptin, Waist-to-hip ratio, Weight, Aromatase inhibitors, Hormonal therapy, BODY-MASS-INDEX, PLASMA LEPTIN, FACTOR-ALPHA, OBESITY, WOMEN, MECHANISMS, ADIPONECTIN, METABOLISM, EXPRESSION, TAMOXIFEN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Our objective was to determine whether serum leptin levels and obesity-related factors could affect outcome for metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs).